Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes. (Q51280706)
Jump to navigation
Jump to search
scientific article published on 27 July 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes. |
scientific article published on 27 July 2016 |
Statements
1 reference
Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes. (English)
1 reference
Jia Liu
1 reference
Yanjin Hu
1 reference
Heng Zhang
1 reference
Yuan Xu
1 reference
Guang Wang
1 reference
27 July 2016
1 reference
30
1 reference
1555-1559
1 reference
8
1 reference
Identifiers
1 reference